Cyara Acquires CentraCX Adding Voice of the Customer (VOC) to Customer Experience Transformation Solutions
20.6.2023 16:00:00 EEST | Business Wire | Press release
Cyara, the leading AI-led Customer Experience (CX) Transformation Platform provider, today announced its acquisition of CentraCX, a comprehensive SaaS-based Voice of the Customer (VOC) solution, designed specifically for the contact center. This acquisition adds advanced VOC and customer feedback capabilities to Cyara’s portfolio of products, solidifying the company’s unique position in the CX Transformation market as the first to offer this combination of CX assurance and customer feedback.
The acquisition of CentraCX compliments Cyara's existing capabilities, bringing valuable insights that inform companies on how to design CX strategies that truly resonate with their target customers. By combining Cyara's expertise in CX assurance with CentraCX's ability to inform CX design with real customer feedback, organizations can continuously transform their CX initiatives and drive customer satisfaction and loyalty.
“Today, with rapidly changing technology and ever increasing customer expectations, delivering a great CX means continuously transforming. This requires the ability to both design a great CX and to deliver it with speed and quality,” said Alok Kulkarni, CEO and Co-founder of Cyara. “With the acquisition of CentraCX, we are uniquely able to offer an AI-enabled CX transformation platform that informs CX design with customer insights and feedback and enables delivery of those designs with speed and quality through automated testing and monitoring.”
CentraCX is designed specifically for the needs of enterprise contact centers, and is integrated with Genesys Cloud CX. It is able to analyze feedback along different organizational lines, allowing for tailored results that cater to different types and levels of stakeholders and empowering frontline managers to use the data to effectively manage their teams. CentraCX can capture and collect data from different channels for analysis and insights, including voice, SMS, web and email. Unique to CentraCX is Tribal Analytics, a technology enabled process that puts customer opinion at the center of business decision making and continual improvement. Tribal Analytics marries customer feedback with the agent perspective, thereby creating a closed loop feedback system that delivers an end-to-end process for driving real change. Going beyond simply identifying actionable insights, Tribal Analytics delivers a framework to support a comprehensive continual improvement program.
Cyara’s latest acquisition is part of an innovation strategy to enable organizations to continuously transform and improve their CX by leveraging insights, automation and AI. With this acquisition, Cyara now offers unmatched expertise and capabilities to drive improvements in an organization’s CX:
- Optimize journeys: Gain valuable insights on how to improve CX design by leveraging customer feedback.
- Continuous CX transformation: Drive ongoing CX improvements with speed and quality by automating testing within an Agile/DevOps framework.
- Enhance chatbots and conversational AI systems: Access our large-language model (LLM) for accelerated training and leverage AI-based automated testing, including natural language processing performance.
- Ensure robust contact center performance: Assure that contact center platforms can handle high-stress situations and enable customers to reach you globally. Additionally, AI-based insights on performance can be provided.
- Monitor remote and at-home agents: Monitor network data to ensure that ISP, home network, and system configurations meet the standards for delivering an excellent CX.
- Seamless communication across channels: Assure reliable and efficient communication across all channels, including voice, digital, SMS, AI chatbots, video, and WebRTC.
Cyara is available now on Genesys AppFoundry. To learn more about this strategic acquisition, visit cyara.com/products/centracx.
About Cyara
Cyara revolutionizes the way businesses transform and optimize their customer experiences. Cyara’s AI-based CX Transformation Platform empowers enterprises to deliver flawless interactions across voice, video, digital, and chatbot experiences. With Cyara, businesses improve customer journeys through continuous innovation while reducing cost and minimizing risk. With a 96% customer retention rate and world-class Net Promoter Score (NPS), today’s leading global brands trust Cyara every day to deliver customer smiles at scale.
To learn more, visit cyara.com or call 1-888-GO-CYARA.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230620911538/en/
Contact information
U.S. Media Contact
Diana Gallagher
+1(408) 656-9699
10Fold Communications for Cyara
cyara@10fold.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 18:16:00 EEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 17:28:00 EEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 16:00:00 EEST | Press release
Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading transformative and meaningful customer experiences. These leading organizations are turning everyday interactions into seamless, cross-channel journeys that deliver meaningful business impact and
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 16:00:00 EEST | Press release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On the demand side, with smart meter integration, Predict+ models each meter individually and performs extensive calculations on actual, historical, and average data to acc
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 15:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
